http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 27 Jan 2026 07:32:31 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/BullFrog+AI+publishes+white+paper+on+data+harmonization/25896105.html <p>BullFrog AI Holdings Inc. (NASDAQ: BFRG; BFRGW) published a white paper titled "Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences" on January 27. The paper discusses the company's bfPREP technology for processing biomedical data.</p><p>The white paper addresses challenges in applying artificial intelligence to pharmaceutical drug development. "The rush to apply AI in biopharma drug development has resulted in many AI initiatives that fail, not due to the algorithm, but due to the resulting analysis that reflect data processing idiosyncrasies rather than biology," said BullFrog AI Founder and CEO Vin Singh.</p><p>The company's bfPREP technology processes raw biomedical data http://www.streetinsider.com/Corporate+News/BullFrog+AI+publishes+white+paper+on+data+harmonization/25896105.html Tue, 27 Jan 2026 07:32:31 +0000 BFRG BFRGW http://www.streetinsider.com/Corporate+News/BullFrog+AI+publishes+white+paper+on+data+harmonization/25896105.html <p>BullFrog AI Holdings Inc. (NASDAQ: BFRG; BFRGW) published a white paper titled "Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences" on January 27. The paper discusses the company's bfPREP technology for processing biomedical data.</p><p>The white paper addresses challenges in applying artificial intelligence to pharmaceutical drug development. "The rush to apply AI in biopharma drug development has resulted in many AI initiatives that fail, not due to the algorithm, but due to the resulting analysis that reflect data processing idiosyncrasies rather than biology," said BullFrog AI Founder and CEO Vin Singh.</p><p>The company's bfPREP technology processes raw biomedical data http://www.streetinsider.com/Corporate+News/BullFrog+AI+publishes+white+paper+on+data+harmonization/25896105.html Tue, 27 Jan 2026 07:32:31 +0000 BFRG BFRGW http://www.streetinsider.com/Press+Releases/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html <p align="justify">GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.</p> <p align="justify">“The rush to apply AI in biopharma http://www.streetinsider.com/Press+Releases/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html Tue, 27 Jan 2026 07:30:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html <p align="justify">GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.</p> <p align="justify">“The rush to apply AI in biopharma http://www.streetinsider.com/Press+Releases/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html Tue, 27 Jan 2026 07:30:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html <p align="justify">GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.</p> <p align="justify">“The rush to apply AI in biopharma http://www.streetinsider.com/Press+Releases/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html Tue, 27 Jan 2026 07:30:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html <p align="justify">GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.</p> <p align="justify">“The rush to apply AI in biopharma http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html Tue, 27 Jan 2026 07:30:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html <p align="justify">GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.</p> <p align="justify">“The rush to apply AI in biopharma http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html Tue, 27 Jan 2026 07:30:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html <p align="justify">GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.</p> <p align="justify">“The rush to apply AI in biopharma http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+on+Data+Harmonization%3A+The+Hidden+Prerequisite%C2%A0for+Reliable+AIML+in+Life+Sciences/25896050.html Tue, 27 Jan 2026 07:30:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html <p>GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=pzRXrgqSUEGKbyGgl_7H1IZr9J88Uwb8sdG7UiGXxa2fKNchM_M9VkDQjJSiMTTL5RexYX68-vBLIr7HUV3bfjjjwsXvoCi17G_xxmZAnBI=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery &amp; Development Summit 2025, taking place November 18–20, 2025, in Boston, Massachusetts.</p> <p>BullFrog AI’s presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will be delivered as part of Technical Insights Session 1 on Wednesday, November 19, 2025. http://www.streetinsider.com/Press+Releases/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html Wed, 12 Nov 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html <p>GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=pzRXrgqSUEGKbyGgl_7H1IZr9J88Uwb8sdG7UiGXxa2fKNchM_M9VkDQjJSiMTTL5RexYX68-vBLIr7HUV3bfjjjwsXvoCi17G_xxmZAnBI=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery &amp; Development Summit 2025, taking place November 18–20, 2025, in Boston, Massachusetts.</p> <p>BullFrog AI’s presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will be delivered as part of Technical Insights Session 1 on Wednesday, November 19, 2025. http://www.streetinsider.com/Press+Releases/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html Wed, 12 Nov 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html <p>GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=pzRXrgqSUEGKbyGgl_7H1IZr9J88Uwb8sdG7UiGXxa2fKNchM_M9VkDQjJSiMTTL5RexYX68-vBLIr7HUV3bfjjjwsXvoCi17G_xxmZAnBI=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery &amp; Development Summit 2025, taking place November 18–20, 2025, in Boston, Massachusetts.</p> <p>BullFrog AI’s presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will be delivered as part of Technical Insights Session 1 on Wednesday, November 19, 2025. http://www.streetinsider.com/Press+Releases/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html Wed, 12 Nov 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html <p>GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=pzRXrgqSUEGKbyGgl_7H1IZr9J88Uwb8sdG7UiGXxa2fKNchM_M9VkDQjJSiMTTL5RexYX68-vBLIr7HUV3bfjjjwsXvoCi17G_xxmZAnBI=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery &amp; Development Summit 2025, taking place November 18–20, 2025, in Boston, Massachusetts.</p> <p>BullFrog AI’s presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will be delivered as part of Technical Insights Session 1 on Wednesday, November 19, 2025. http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html Wed, 12 Nov 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html <p>GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=pzRXrgqSUEGKbyGgl_7H1IZr9J88Uwb8sdG7UiGXxa2fKNchM_M9VkDQjJSiMTTL5RexYX68-vBLIr7HUV3bfjjjwsXvoCi17G_xxmZAnBI=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery &amp; Development Summit 2025, taking place November 18–20, 2025, in Boston, Massachusetts.</p> <p>BullFrog AI’s presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will be delivered as part of Technical Insights Session 1 on Wednesday, November 19, 2025. http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html Wed, 12 Nov 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html <p>GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=pzRXrgqSUEGKbyGgl_7H1IZr9J88Uwb8sdG7UiGXxa2fKNchM_M9VkDQjJSiMTTL5RexYX68-vBLIr7HUV3bfjjjwsXvoCi17G_xxmZAnBI=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery &amp; Development Summit 2025, taking place November 18–20, 2025, in Boston, Massachusetts.</p> <p>BullFrog AI’s presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will be delivered as part of Technical Insights Session 1 on Wednesday, November 19, 2025. http://www.streetinsider.com/Globe+Newswire/BullFrog+AI+to+Present+bfPREP+at+the+AI+Drug+Discovery+%26amp%3B+Development+Summit+2025/25592769.html Wed, 12 Nov 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html <p align="left">GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MNnmgCFcSijmDGdnt-9Pogfk176NCv5_92h383zXWGJv6-xEgMXZtOKlBn2MolT2vzum9b7Lug6hAQBn2cQw2FTVHi-JvC8HnOjhA8T8VYw=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET.</p> <p>The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven http://www.streetinsider.com/Press+Releases/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html Thu, 30 Oct 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html <p align="left">GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MNnmgCFcSijmDGdnt-9Pogfk176NCv5_92h383zXWGJv6-xEgMXZtOKlBn2MolT2vzum9b7Lug6hAQBn2cQw2FTVHi-JvC8HnOjhA8T8VYw=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET.</p> <p>The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven http://www.streetinsider.com/Press+Releases/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html Thu, 30 Oct 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html <p align="left">GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MNnmgCFcSijmDGdnt-9Pogfk176NCv5_92h383zXWGJv6-xEgMXZtOKlBn2MolT2vzum9b7Lug6hAQBn2cQw2FTVHi-JvC8HnOjhA8T8VYw=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET.</p> <p>The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven http://www.streetinsider.com/Press+Releases/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html Thu, 30 Oct 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html <p align="left">GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MNnmgCFcSijmDGdnt-9Pogfk176NCv5_92h383zXWGJv6-xEgMXZtOKlBn2MolT2vzum9b7Lug6hAQBn2cQw2FTVHi-JvC8HnOjhA8T8VYw=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET.</p> <p>The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven http://www.streetinsider.com/Globe+Newswire/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html Thu, 30 Oct 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html <p align="left">GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MNnmgCFcSijmDGdnt-9Pogfk176NCv5_92h383zXWGJv6-xEgMXZtOKlBn2MolT2vzum9b7Lug6hAQBn2cQw2FTVHi-JvC8HnOjhA8T8VYw=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET.</p> <p>The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven http://www.streetinsider.com/Globe+Newswire/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html Thu, 30 Oct 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html <p align="left">GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MNnmgCFcSijmDGdnt-9Pogfk176NCv5_92h383zXWGJv6-xEgMXZtOKlBn2MolT2vzum9b7Lug6hAQBn2cQw2FTVHi-JvC8HnOjhA8T8VYw=" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET.</p> <p>The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven http://www.streetinsider.com/Globe+Newswire/Join+BullFrog+AI%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+30/25525485.html Thu, 30 Oct 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html <p><strong><em>From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence</em></strong></p> <p><strong><em>In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded, composition-aware analytics that guide smarter therapeutic decisions</em></strong></p> <p>GAITHERSBURG, Md., July 22, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ER9cNXrx8WB8FU0RiZJt4RfW1NWba8IVMKQam_gZ25ePmwWIwZO0inlS8XjNawRvEVFWdYRmJdHaO5VXKj6Jszy9YAJu712wNFGr9iK3iD4xyrB1HDeYUmoE7fBqMokLvYwJ68H2Ld5aj86cwXdFMMW8VeRhj4SBhHzWzhXaBsNnjg4sINEZBpkYVpkzQFcuNLXrn9xaJkYizn5f_6juEVJRFvr-JtXTy7xsCkhNVb6qdQdRvoFHE_AELl1duxD41k7X1OqKdqnq0SgC35Lz5nSJiUVZ_XcpFngQ3z-7JN1RoiQjPrQ64CxRSMw9uy12LNG_aMu2KAkFXcRksAEAHqVsaCMqssCbRjtlE65L9MWoxTsEvkX3pKmgRavRDsyDOPkostMfSHuAQiZW7NoIbiGofBH8yr9iZ5d20Yz-Uxyr_ANjm4dyh6zNk4FDT2zGPq9sT1Om4m-x4tRNXZjbxDR9nbIY9F3flr24JaKtFP8D6wTDVUrtNsRNxYFFogSL" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of a new http://www.streetinsider.com/Press+Releases/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html Tue, 22 Jul 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html <p><strong><em>From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence</em></strong></p> <p><strong><em>In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded, composition-aware analytics that guide smarter therapeutic decisions</em></strong></p> <p>GAITHERSBURG, Md., July 22, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ER9cNXrx8WB8FU0RiZJt4RfW1NWba8IVMKQam_gZ25ePmwWIwZO0inlS8XjNawRvEVFWdYRmJdHaO5VXKj6Jszy9YAJu712wNFGr9iK3iD4xyrB1HDeYUmoE7fBqMokLvYwJ68H2Ld5aj86cwXdFMMW8VeRhj4SBhHzWzhXaBsNnjg4sINEZBpkYVpkzQFcuNLXrn9xaJkYizn5f_6juEVJRFvr-JtXTy7xsCkhNVb6qdQdRvoFHE_AELl1duxD41k7X1OqKdqnq0SgC35Lz5nSJiUVZ_XcpFngQ3z-7JN1RoiQjPrQ64CxRSMw9uy12LNG_aMu2KAkFXcRksAEAHqVsaCMqssCbRjtlE65L9MWoxTsEvkX3pKmgRavRDsyDOPkostMfSHuAQiZW7NoIbiGofBH8yr9iZ5d20Yz-Uxyr_ANjm4dyh6zNk4FDT2zGPq9sT1Om4m-x4tRNXZjbxDR9nbIY9F3flr24JaKtFP8D6wTDVUrtNsRNxYFFogSL" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of a new http://www.streetinsider.com/Press+Releases/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html Tue, 22 Jul 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Press+Releases/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html <p><strong><em>From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence</em></strong></p> <p><strong><em>In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded, composition-aware analytics that guide smarter therapeutic decisions</em></strong></p> <p>GAITHERSBURG, Md., July 22, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ER9cNXrx8WB8FU0RiZJt4RfW1NWba8IVMKQam_gZ25ePmwWIwZO0inlS8XjNawRvEVFWdYRmJdHaO5VXKj6Jszy9YAJu712wNFGr9iK3iD4xyrB1HDeYUmoE7fBqMokLvYwJ68H2Ld5aj86cwXdFMMW8VeRhj4SBhHzWzhXaBsNnjg4sINEZBpkYVpkzQFcuNLXrn9xaJkYizn5f_6juEVJRFvr-JtXTy7xsCkhNVb6qdQdRvoFHE_AELl1duxD41k7X1OqKdqnq0SgC35Lz5nSJiUVZ_XcpFngQ3z-7JN1RoiQjPrQ64CxRSMw9uy12LNG_aMu2KAkFXcRksAEAHqVsaCMqssCbRjtlE65L9MWoxTsEvkX3pKmgRavRDsyDOPkostMfSHuAQiZW7NoIbiGofBH8yr9iZ5d20Yz-Uxyr_ANjm4dyh6zNk4FDT2zGPq9sT1Om4m-x4tRNXZjbxDR9nbIY9F3flr24JaKtFP8D6wTDVUrtNsRNxYFFogSL" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of a new http://www.streetinsider.com/Press+Releases/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html Tue, 22 Jul 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html <p><strong><em>From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence</em></strong></p> <p><strong><em>In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded, composition-aware analytics that guide smarter therapeutic decisions</em></strong></p> <p>GAITHERSBURG, Md., July 22, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ER9cNXrx8WB8FU0RiZJt4RfW1NWba8IVMKQam_gZ25ePmwWIwZO0inlS8XjNawRvEVFWdYRmJdHaO5VXKj6Jszy9YAJu712wNFGr9iK3iD4xyrB1HDeYUmoE7fBqMokLvYwJ68H2Ld5aj86cwXdFMMW8VeRhj4SBhHzWzhXaBsNnjg4sINEZBpkYVpkzQFcuNLXrn9xaJkYizn5f_6juEVJRFvr-JtXTy7xsCkhNVb6qdQdRvoFHE_AELl1duxD41k7X1OqKdqnq0SgC35Lz5nSJiUVZ_XcpFngQ3z-7JN1RoiQjPrQ64CxRSMw9uy12LNG_aMu2KAkFXcRksAEAHqVsaCMqssCbRjtlE65L9MWoxTsEvkX3pKmgRavRDsyDOPkostMfSHuAQiZW7NoIbiGofBH8yr9iZ5d20Yz-Uxyr_ANjm4dyh6zNk4FDT2zGPq9sT1Om4m-x4tRNXZjbxDR9nbIY9F3flr24JaKtFP8D6wTDVUrtNsRNxYFFogSL" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of a new http://www.streetinsider.com/Globe+Newswire/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html Tue, 22 Jul 2025 08:00:00 +0000 BFRG BFRGW O.56621805 http://www.streetinsider.com/Globe+Newswire/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html <p><strong><em>From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence</em></strong></p> <p><strong><em>In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded, composition-aware analytics that guide smarter therapeutic decisions</em></strong></p> <p>GAITHERSBURG, Md., July 22, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ER9cNXrx8WB8FU0RiZJt4RfW1NWba8IVMKQam_gZ25ePmwWIwZO0inlS8XjNawRvEVFWdYRmJdHaO5VXKj6Jszy9YAJu712wNFGr9iK3iD4xyrB1HDeYUmoE7fBqMokLvYwJ68H2Ld5aj86cwXdFMMW8VeRhj4SBhHzWzhXaBsNnjg4sINEZBpkYVpkzQFcuNLXrn9xaJkYizn5f_6juEVJRFvr-JtXTy7xsCkhNVb6qdQdRvoFHE_AELl1duxD41k7X1OqKdqnq0SgC35Lz5nSJiUVZ_XcpFngQ3z-7JN1RoiQjPrQ64CxRSMw9uy12LNG_aMu2KAkFXcRksAEAHqVsaCMqssCbRjtlE65L9MWoxTsEvkX3pKmgRavRDsyDOPkostMfSHuAQiZW7NoIbiGofBH8yr9iZ5d20Yz-Uxyr_ANjm4dyh6zNk4FDT2zGPq9sT1Om4m-x4tRNXZjbxDR9nbIY9F3flr24JaKtFP8D6wTDVUrtNsRNxYFFogSL" rel="nofollow" target="_blank">BullFrog AI Holdings, Inc.</a> (NASDAQ: BFRG; BFRGW) (&quot;BullFrog AI&quot; or the &quot;Company&quot;), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of a new http://www.streetinsider.com/Globe+Newswire/Rethinking+R%26amp%3BD%3A+BullFrog+AI+White+Paper+Outlines+New+Blueprint+for+Smarter+Drug+Development/25078365.html Tue, 22 Jul 2025 08:00:00 +0000 BFRG BFRGW O.56621805